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Figure S1.  Circular dichroism spectroscopy for 5 μM α3DH3 (red) and 5 μM Zn(II)α3DH3 (blue) at pH 9.0.  
Left: Spectra showing α-helical nature of fully-folded peptides. Apo-α3DH3 and Zn(II)α3DH3 are initially 
82% and 83% folded, respectively. Right: Guanidine hydrochloride denaturations.  Fittings reveal ΔGu = 
3.4 kcal/mol for apo- α3DH3 and 3.5 kcal/mol for Zn(II)-α3DH3. 
 
  
Figure S2.  Competitive Zincon binding titrations at pH 7.5 with α3DH3.  In triplicate, plots show the 
absorbance of Zn(II)-Zincon at 620 nm plotted against the titrant concentration.  Left: Titration of α3DH3 
into Zn(II)-Zincon (10 μM Zincon, 5 μM ZnSO4, 50 mM HEPES).  Right: Titration of Zincon into Zn(II)α3DH3 
(10 μM α3DH3, 5 μM ZnSO4, 50 mM HEPES). 
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Figure S3.  Competitive Zincon binding titrations at pH 9.0 with α3DH3.  In triplicate, plots show the 
absorbance of Zn(II)-Zincon at 620 nm plotted against the titrant concentration.  Left: Titration of α3DH3 
into Zn(II)-Zincon (10 μM Zincon, 5 μM ZnSO4, 50 mM CHES).  Right: Titration of Zincon into Zn(II)α3DH3 
(10 μM α3DH3, 5 μM ZnSO4, 50 mM CHES). 
 
 
 
 
 
 
 
 
 
Figure S4.  Competitive Zincon binding titrations at pH 9.0 with α3DH72V.  In triplicate, plots show the 
absorbance of Zn(II)-Zincon at 620 nm plotted against the titrant concentration.  Left: Titration of 
α3DH72V into Zn(II)-Zincon (8 μM Zincon, 4 μM ZnSO4, 50 mM CHES).  Right: Titration of Zincon into 
Zn(II)α3DH72V (40 μM α3DH72V, 4 μM ZnSO4, 50 mM CHES). 
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Figure S5.  CO2 hydration rates plotted versus substrate concentration at pH 9.5.  The activity of 
Zn(II)α3DH3 (purple triangles) is significantly higher than any of the controls, showing that the activity 
results from the Zn(II)N3O site. Apo-α3DH72V shows some activity (green triangles), but it is not 
enhanced by the addition of ZnSO4 (red circles), showing that adventitiously-bound Zn(II) does not 
contribute to the activity.  Free Zn(II) shows minimal activity (blue squares). 
 
 
 
 
 
 
 
Figure S6.  Michaelis-Menten plot for the hydration catalysis of CO2 hydration by 100 μM Zn(II)α3DH3 at 
pH 8.5 in the absence and presence of potassium acetate inhibitor. 
 
 
 
Table S1.  Kinetic parameters for the catalysis of CO2 hydration by Zn(II)α3DH3 at pH 8.5 in the absence 
and presence of potassium acetate inhibitor. 
KOAC (mM) kcat (s-1) KM (mM) kcat/KM (M-1s-1) 
0 82 ± 6 7.2 ± 1.1 11,400 ± 1,100 
300 67 ± 4 6.2 ± 0.8 10,700 ± 800 
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Experimental Section 
 
Expression and Purification of α3DH3 
The synthetic DNA for α3DH3 was cloned into a pET-15b vector (Celtek Genes) and expressed in E. coli 
BL21(DE3) competent cells (Invitrogen) in self-inducing media.  The cells were lysed by sonication and 
the soluble protein was isolated after heat denaturation (55 °C) and acidification to pH 1.9.  The 
lyophilized powder was redissolved and purified using reverse-phase HPLC with a linear gradient of H2O 
to 9:1 CH3CN/H2O over 50 minutes.  All HPLC solvents contained 0.1% trifluoroacetic acid.  The purified 
protein had a yield of 230 mg/L and a molecular weight of 8283.5 Da by ESI-MS (collected on a 
Micromass LCT Time-of-Flight Mass Spectrometer).  This compares well to the calculated mass of 8283.1 
Da for α3DH3 lacking formyl-methionine.  The concentration of the protein was determined by 
measuring the absorbance at 280 nm using the measured molar extinction coefficient of 7849 mol-1cm-1. 
 
Expression and Purification of α3DH72V 
Using the GeneArt® Site-Directed Mutagenesis System (Invitrogen), the codon for His72 was mutated to 
that for Val within the α3D gene (pET-15a vector).  The resulting plasmid was expressed and purified as 
described above with a yield of 100 mg/L.  The molecular weight of the pure protein was determined to 
be 7938.4 Da by ESI-MS, which compares well to the calculated mass of 7938.9 Da for α3DH72V lacking 
formyl-methionine. 
 
Circular Dichroism (CD) Spectroscopy 
CD spectra were collected on an Aviv 202 CD Spectrometer at 25 °C using 1 cm path length open top 
quartz cuvettes.  Samples were prepared at pH 9.0 in 10 mM potassium phosphate (ion source) and 
contained either 5 μM peptide or 5 μM peptide and 15 μM ZnSO4.  The percent folding was based on the 
presence of 59 helical residues and was determined using previously reported procedures.1,2  Guanidine 
hydrochloride (GuaHCl) titrations were carried out using a Microlab 500 series syringe-pump automatic 
titrator controlled by Aviv software.  Into a solution of 5 μM α3DH3 or 5 μM Zn(II)-α3DH3 in 10 mM KPhos 
at pH 9.0, GuaHCl was titrated to a concentration of 6.5 M, while keeping the protein concentration 
constant.  The change in molar ellipticity upon titration was fit to a two-state unfolding model.3 
 
Zn(II) Binding Constant Determination 
The dissociation constants for Zn(II) to α3DH3 and α3DH72V were determined at pH 7.5 and 9.0 at 25 °C 
following our previously reported procedures.4 
 
CO2 Hydration Kinetics 
The initial rates for CO2 hydration catalyzed by Zn(II)-α3DH3 were measured at 25.0 °C on an OLIS RSM 
Stopped Flow Spectrophotometer using Khalifah’s changing pH-indicator method.5  The substrate stock 
solution was prepared by bubbling CO2 (Matheson Tri-Gas, Inc., Research Grade) through deionized 
water for at least 20 minutes and then diluted with deionized water in a gas-tight syringe.  This substrate 
solution was mixed by the stopped-flow with either a control solution (containing only buffer, indicator, 
and apo-α3DH3) or a catalyst solution (containing buffer, indicator, Zn(II)-α3DH3, and apo-α3DH3).  After 
1:1 mixing with the substrate solution, each shot contained 50 mM buffer and 25 μM indicator and were 
maintained at 0.1 M ionic strength with Na2SO4.  Typically, the control shots contained 10 μM apo-
α3DH3, while the catalyst shots contained 110 μM α3DH3 and 100 μM ZnSO4, ensuring a final Zn(II)α3DH3 
concentration of 100 μM.  The buffer indicator pairs used were TAPS/m-cresol purple (pH 8-8.75, λ = 578 
nm, Δϵ = 35,000 M-1cm-1), AMPSO/thymol blue (pH 8.75-9.25, λ = 590 nm, Δϵ = 40,500 M-1cm-1), and 
CHES/thymol blue (pH 9.25-9.5, λ = 590 nm, Δϵ = 40,500 M-1cm-1).    The experimental buffer factors 
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were close to those which were calculated theoretically, allowing for the CO2 concentrations to be 
checked throughout the experiment.5  Upon rapid mixing of the substrate solution with the 
buffer/indicator solution by the stopped-flow spectrophotometer, several seconds of absorbance data 
was collected.  Initial rates were determined from the initial linear portion of the reaction (usually less 
than the first 10%).  The rates from 6-11 replicates were averaged and, at each substrate concentration, 
the rate for the control solution was subtracted from that of the catalyst.  The difference, reflecting the 
initial rate of the catalyst, was plotted as a function of [CO2] and fitted using the Michaelis-Menten 
equation (in GraphPad Prism 5).  Inhibition experiments were carried out as described above, with the 
addition of 300 mM KOAc to the buffer/indicator solution at pH 8.5. 
 
EXAFS 
Samples for EXAFS were prepared with final concentrations of 1 mM ZnSO4, 1.5 mM α3DH3, 50 mM CHES 
buffer, and 4.1 M glycerol at pH 9.0.  At these concentrations, >99.9% of the Zn(II) is bound to α3DH3.  
The samples were rapidly frozen in liquid N2 and maintained at ~10K throughout the measurements.  
EXAFS data were measured at SSRL Beamline 7-3 using a Si(220) double crystal monochromator and a 
Rh-coated vertically collimating harmonic rejection monochromator.  Data were measured as 
fluorescence excitation spectra using a 30-element energy-resolving Ge detector.  Data were collected 
using 10 eV steps in the pre-edge region (9350 - 9640 eV), 0.25 eV for the edge region (9640 - 9690 eV), 
and 0.05 Å-1 increments for the extended x-ray absorption fine structure (EXAFS) region to k=13  Å-1, 
with integration times of 1 s in the pre-edge and edge regions and 1-20 s (k3 weighted) in the EXAFS 
region for a total scan time of ~40 min. 
 
Raw data were converted to EXAFS and fit using the EXAFSPAK6 suite of programs, with theoretical 
amplitude and phase parameters calculated using FEFF 97 using  two metal-ligand distances, the Debye-
Waller factors for the Zn-O  and Zn-histidine shells (1.6 x 10-3 Å2 and 5.6 x 10-3 Å2, respectively) and E0 
(-8.3 eV) as the only adjustable parameters.  The remaining histidine distances assuming a rigid 
imidazole ring with distances and angles equal to the average of Zn-histidine models found in the 
Cambridge Crystallographic database and the imidazole Debye-Waller factors were defined by assuming 
that the 2 value for each scattering path increased proportionally from those calculated by Bunker and 
Dimakis for an ordered imidazole.8 
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